Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 15Prostatic Neoplasms 9Colorectal Neoplasms 7Ovarian Neoplasms 5Endometrial Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Brain Neoplasms 3Wilms Tumor 2Urogenital Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Syndromes, Hereditary 2Neoplasms, Unknown Primary 2Neoplasm Metastasis 2Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Leukemia 2Kidney Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Glioma 2

Interventions

Exercise 4Cholecalciferol 4Aspirin 4Nutrition Assessment 3Gonadotropin-Releasing Hormone 3Blood Pressure 3Atorvastatin 3palbociclib 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2acalabrutinib 2Vitamin E 2Vitamin D 2Social Determinants of Health 2Rosuvastatin Calcium 2Methods 2Metformin 2Geritol 2Fish Oils 2Fatty Acids, Omega-3 2Ethanol 2Electrocardiography 2Educational Status 2Echocardiography 2Diet, Mediterranean 2Blood Specimen Collection 2Absorptiometry, Photon 2zanubrutinib 1xinmailong 1sofosbuvir-velpatasvir drug combination 1ribociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Genetic Testing × Clear all
NCT02485626 2016-10-31

HARBOR

The Netherlands Cancer Institute

Unknown
628 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡